For a long time, it was believed that varicose veins could only be corrected by removing large superficial veins and ligating the perforating veins. When CHIVA was introduced in 1988, many surgeons met it with hostility. The method was not widely used because it contradicted the basic concepts of varicose vein treatment.
Ventral abdominal hernias are any defects of the abdominal wall fascia, except inguinal and hiatal hernias. Millions of surgeries for these conditions are performed worldwide each year. Most of them are carried out in an open manner, under visual control. But in developed countries, minimally invasive surgery is preferred, including laparoscopic and robot-assisted techniques.
According to official statistics from the WHO in 2022, oncological diseases are now the cause of one in every six deaths worldwide. This has encouraged the international medical community to develop new cancer treatment methods and increase the effectiveness of the already existing ones. This is particularly important for patients...
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new treatment option for peritoneal carcinomatosis. The technique was developed in 2011 by scientists from the University Hospital of Louisiana, USA. The authors suggested PIPAC as an alternative to HIPEC (hyperthermic intraperitoneal chemotherapy) in patients with peritoneal lesions against the background of diverse oncologic diseases.
Immunotherapy is one of the most effective treatment options for lymphoma. It is used in combination with chemotherapy and has also become a life-saving treatment for many patients whose tumor has recurred and chemotherapy is no longer working. Some types of immunotherapy are so effective that they can even cure aggressive end-stage lymphomas.
Immunotherapy is the most rapidly developing area of cancer treatment in the 21st century. Many methods and drugs have already been approved that significantly improve the results of cancer therapy, especially in the advanced stages. Immunotherapy causes immune cells to attack cancer cells more actively.
In recent years, doctors in developed countries have increasingly used immunotherapy treatment for leukemia. Healthcare professionals in Germany use innovative drugs that help cope with even refractory and relapsing forms of leukemia. Immunotherapy is mainly used for acute lymphocytic leukemia.
Immunotherapy is the most rapidly developing area of oncology. It is used for most types of cancer. Moreover, some tumors are much more sensitive to immunotherapy than others, and kidney cancer also belongs to this group of tumors. Immunotherapy is very successful for this disease and can be used at almost all stages in order to lower the risk of relapse after surgery and control metastatic tumors.